Toolrite appoints sales director

Steve Gannon takes newly formed position

Pharmaceutical engineering specialist Toolrite, based in Brentwood, UK, has appointed Steve Gannon to the position of sales director.

With more than 30 years’ experience in technical support and then sales in the cosmetics, toiletries and pharmaceutical packaging industries, Gannon joins Toolrite from German pharmaceutical organisation Uhlmann, where he held the role of sales manager for 10 years.

Gaining an HND in Mechanical & Production Engineering, Gannon further strengthened his technical expertise as sales engineer with Uhlmann agent, Ultrapac.

You may also like

Manufacturing

Thermo Fisher expands collaboration Multiply Labs for automated cell therapy manufacturing

The strategic collaboration will aim to integrate robot automation with the Gibco CTS DynaCellect Magnetic Separation System for a more efficient manufacturing process
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Human-machine symbiosis: why Industry 5.0 is the future of pharmaceutical manufacturing

Industry 5.0 is reshaping pharmaceutical manufacturing by fostering human-machine collaboration, addressing workforce shortages and making advanced automation accessible to all through innovative models such as robot rental
Manufacturing

The future of powder dispersion

ystral presented high-shear vacuum expansion technology at POWTECH
Manufacturing

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
Manufacturing

Indena accelerates CDMO innovation with advanced facilities and cutting-edge tech

In 2025, Indena completed several facility upgrades that have increased the quality, versatility and reliability of the CDMO services it offers for partners
Manufacturing

Automate Reactex glass reactor systems easily with Hitec Zang

Labtex, backed by more than 20 years of expertise in specialist laboratory and process chemistry equipment, is bringing advanced automation to its REACTEX glass reactor systems through innovative solutions from Hitec Zang
Finance

Genmab to acquire Merus in $8bn deal to expand late-stage pipeline

The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027
Subscribe now